Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment
- PMID: 15502140
- PMCID: PMC7976424
Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment
Abstract
Background and purpose: Diffusion tensor (DT) images can provide information about the nature of white matter changes, including axonal loss and demyelination. We applied DT imaging to verify white matter changes in patients with malignant phenylketonuria (PKU) and to correlate the findings with clinical intelligence quotients (IQs).
Methods: We compared DT images with T2-weighted images in 12 patients with early-treated, chronic, stable malignant PKU and 12 age-matched control subjects. DT parameters included first, second, and third eigenvalues (EV1-3), apparent diffusion coefficients (ADCs), and fractional anisotropy (FA). Regions of interest were placed the frontoparietal, parieto-occipital, frontal and central white matter and in the anterior and posterior corpus callosum. Eight patients older than 3 years underwent IQ assessment including verbal, performance, and full-scale IQ tests.
Results: In the eight patients older than 3 years, no definite abnormal signal intensity changes were found on T2-weighted images. EV2, EV3, and FA of the parieto-occipital white matter were significantly different in patients and control subjects older than 3 years. EV3 and ADC of the parieto-occipital white matter were significantly and negatively correlated with verbal IQ (r = -0.79, P = .04) and performance IQ (r = -0.93, P = .03). FA of the parieto-occipital central white matter was positively correlated with verbal IQ (r = 0.75, P = .05).
Conclusion: Though treated early, patients with chronic, stable malignant PKU had abnormal DT findings in the parieto-occipital central white matter. EV2, EV3, and FA maps are potential tools for demonstrating brain changes due to malignant PKU.
Copyright American Society of Neuroradiology
Figures


References
-
- Mallolas J, Vilaseca MA, Campisto J, et al. Clinical, biochemical, neurological and molecular study of 11 patients with new mutations in PAH gene. Rev Neurol 2000;31:907–910 - PubMed
-
- Scriver CR. Science, medicine and phenylketonuria. Acta Paediatr 1995;407(Suppl):11–18 - PubMed
-
- Lou HC, Guttler F, Lykkelung C, et al. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 1985;144:17–20 - PubMed
-
- Pratt OE. Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases. J Inherit Metab Dis 1979;2(Suppl 5):75–81
-
- Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679–688 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical